Sign in
Taking people in United StatesNo phase

A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

Key facts

Who runs it
Hoffmann-La Roche
Where
Carmel, Charlotte, Cincinnati, Houston, Madison, Manhasset, Milwaukee, Nashville, Philadelphia, Pittsburgh, Providence, Sacramento, Salt Lake City, and San Francisco, United StatesSee the 14 sites
Trial code
Status
Recruiting
People taking part
2,000 people, planned
Started
9 Feb 2026
Expected to end
23 Nov 2028
Type of study
Observational, 2 groups
Treatments tested
  • Blood sample collection
Record updated
13 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Presenting to the Emergency Department with a biomechanically plausible mechanism of non-penetrating traumatic brain injury (TBI; direct impact: blow to the head, head against object, object against head; acceleration/deceleration)
  • Acute brain CT completed for standard of care; Further Inclusion Criteria (specific for CLIN12.2):
  • Admitted to the hospital with radiographic evidence of acute TBI
  • Admitted to the intensive care unit at risk for decline related to TBI

Who cannot take part

  • Prior neurosurgical intervention within the last 6 months
  • Received chemotherapy or radiation currently or within the last year
  • Currently receiving any interventional treatments as a part of an investigational study/trial (drug, device, behavioral, treatment) at the time of enrollment and/or during the course of this study
  • Major debilitating neurological disease (such as, but not limited to: stroke, CVA, mild cognitive impairment, Alzheimer's disease, Amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, Frontotemporal dementia, tumor, epilepsy, unmanaged seizure disorder), impairing baseline awareness, cognition, or validity of outcomes assessments
  • Major debilitating baseline mental health disorders (such as but not limited to schizophrenia or bipolar disorder) that would interfere with follow-up and the validity of outcome assessments
  • Significant pre-existing conditions that would interfere with follow-up and outcome assessment (such as, but not limited to: chronic kidney disease, chronic cardiovascular comorbidities, alcohol or substance use disorder)
  • History of melanoma
  • Primary diagnosis of ischemic or hemorrhagic stroke
  • Patients on psychiatric hold (e.g., 5150, 5250)
  • Any condition that, in the opinion of the investigator, could interfere in the proper execution of the study procedures and/or in their future permanence in the study
  • Any spinal Cord Injury (American Spinal Injury Association [ASIA] score of A-D)
  • Current incarceration or in custody
  • Known inability to undergo an MRI
  • Low likelihood of follow-up (e.g. participant or family indicating low interest, residence in another state or country, homelessness or lack of reliable contacts)

Where in United States

  • Goodman Campbell Brain and Spine/AscensionCarmel, United StatesContact: Marian MartinezNot yet recruiting
  • Atrium Health - Carolina Medical CenterCharlotte, United StatesContact: Marian MartinezTaking people
  • University of CincinnatiCincinnati, United StatesContact: Marian MartinezTaking people
  • Baylor College of MedicineHouston, United StatesContact: Marian MartinezNot yet recruiting
  • University of WisconsinMadison, United StatesContact: Marian MartinezNo longer taking part
  • Northwell Health - Department Of NeurosurgeryManhasset, United StatesContact: Marian MartinezNot yet recruiting
  • Medical College of WisconsinMilwaukee, United StatesContact: Marian MartinezNot yet recruiting
  • Vanderbilt University Medical CenterNashville, United StatesContact: Marian MartinezNot yet recruiting
  • University of Pennsylvania Medical CenterPhiladelphia, United StatesContact: Marian MartinezTaking people
  • University of Pittsburgh Medical CenterPittsburgh, United StatesContact: Marian MartinezTaking people
  • Brown UniversityProvidence, United StatesContact: Marian MartinezNot yet recruiting
  • University Of California Davis, Neurological SurgerySacramento, United StatesContact: Marian MartinezTaking people
  • University of UtahSalt Lake City, United StatesContact: Marian MartinezNot yet recruiting
  • University of California San FranciscoSan Francisco, United StatesContact: Marian MartinezTaking people

About the trial

What the trial wants to find out

The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary events in adult participants diagnosed with TBI (CLIN12.2).

The 2 groups in the trial

  • Cohort 1: Participants with Suspected TBI

    Treatment: Blood sample collection

  • Cohort 2: Hospitalized Participants with TBI

    Treatment: Blood sample collection

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter Prospective Study to Develop a Blood-based Biomarker Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adult Subjects (CLIN12.1) and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury (CLIN12.2)
Record updated
13 November 2026